AMEX Stocks in Focus: Palatin Technologies, Hemispherx BioPharma, ADVENTRX Pharmaceuticals, BioTime

Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Palatin Technologies, Inc.(NYSEAMEX:PTN) added 5.43% and is trading at $0.643. Palatin Technologies, Inc. (Palatin) is a biopharmaceutical company engaged in the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems.

How Should Investors Trade PTN After The Recent Movement? Find Out Here

Hemispherx BioPharma, Inc(NYSEAMEX:HEB) is lower 2.27% and is trading at $0.215. Hemispherx Biopharma, Inc. (Hemispherx) is a specialty pharmaceutical company engaged in the clinical development of new drugs therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Is HEB Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

ADVENTRX Pharmaceuticals, Inc.(NYSEAMEX:ANX) added 1.30% and is trading at $.780. ADVENTRX Pharmaceuticals, Inc. Operates as a biopharmaceutical research and development company. The Company's business strategy is to commercialize leading edge medical research through licensing agreements with prominent universities and research institutions.

Is ANX a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

BioTime, Inc.(NYSEAMEX:BTX) is lower 1.43% and is trading at $4.15. BioTime, Inc. is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases.

How Should Investors Trade BTX After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.